Immunocore Ownership | Who Owns Immunocore?
Immunocore Ownership Summary
Immunocore is owned by 101.74% institutional investors, 0.07% insiders. Wellington management group llp is the largest institutional shareholder, holding 11.27% of IMCR shares. Vanguard Health Care Inv is the top mutual fund, with 8.35% of its assets in Immunocore shares.
IMCR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immunocore | 101.74% | 0.07% | -1.80% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Wellington management group llp | 5.72M | 11.27% | $181.67M |
| Rtw investments, lp | 4.87M | 9.59% | $154.62M |
| Fmr | 4.31M | 8.49% | $136.76M |
| Primecap management co/ca/ | 3.64M | 7.17% | $115.51M |
| Bellevue group | 2.79M | 5.49% | $88.53M |
| Tang capital management | 2.65M | 5.22% | $84.12M |
| Vestal point capital, lp | 1.80M | 3.55% | $57.15M |
| Two sigma investments, lp | 1.65M | 3.25% | $52.36M |
| Millennium management | 1.60M | 3.15% | $50.71M |
| Armistice capital | 1.43M | 2.81% | $45.34M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tang capital management | 2.65M | 3.82% | $84.12M |
| Kynam capital management, lp | 1.38M | 2.41% | $43.66M |
| Caligan partners lp | 1.38M | 2.06% | $43.86M |
| Bellevue group | 2.79M | 1.86% | $88.53M |
| Vestal point capital, lp | 1.80M | 1.34% | $57.15M |
| Rtw investments, lp | 4.87M | 1.32% | $154.62M |
| Bvf inc/il | 1.29M | 1.05% | $41.10M |
| Diadema partners lp | 254.86K | 1.02% | $8.09M |
| Catalio capital management, lp | 148.04K | 0.88% | $4.70M |
| Logos global management lp | 600.00K | 0.82% | $19.05M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Caligan partners lp | 1.38M | 2.06% | 1.38M |
| Wellington management group llp | 5.72M | 0.03% | 1.02M |
| Acadian asset management | 1.21M | 0.05% | 708.80K |
| Two sigma investments, lp | 1.65M | 0.04% | 627.72K |
| Braidwell lp | 521.33K | 0.61% | 521.33K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| T. rowe price investment management | - | - | -1.89M |
| Paradigm biocapital advisors lp | - | - | -1.79M |
| Deep track capital, lp | 311.22K | 0.14% | -1.62M |
| General atlantic | - | - | -1.26M |
| Fiera capital | - | - | -1.08M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Caligan partners lp | 1.38M | 2.06% | 1.38M | $43.86M |
| Braidwell lp | 521.33K | 0.61% | 521.33K | $16.55M |
| Boothbay fund management | 295.55K | 0.12% | 295.55K | $9.38M |
| Qube research | 223.12K | 0.01% | 223.12K | $7.08M |
| Axa investment managers | 95.17K | 0.01% | 95.17K | $3.46M |
Sold Out
| Holder | Change |
|---|---|
| Dv trading | -5.00 |
| Nelson, van denburg & campbell wealth management group | -6.00 |
| Ronald blue trust | -6.00 |
| Northwestern mutual wealth management | -7.00 |
| Geneos wealth management | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 144 | -5.88% | 51,637,195 | -1.44% | 101 | 0.95% | 77 | 2.67% | 40 | -4.76% |
| Mar 31, 2026 | 82 | -48.10% | 9,968,249 | -80.66% | 19 | 0.19% | 34 | -56.96% | 28 | -31.71% |
| Dec 31, 2025 | 97 | -32.64% | 12,862,798 | -74.16% | 25 | 0.26% | 49 | -19.67% | 24 | -48.94% |
| Sep 30, 2025 | 136 | -1.45% | 49,176,961 | 2.73% | 97 | 1.08% | 60 | -16.67% | 43 | 7.50% |
| Jun 30, 2025 | 141 | 11.90% | 48,351,355 | 0.95% | 96 | 1.05% | 74 | 23.33% | 40 | 25.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 4.25M | 8.35% | 588.47K |
| Vanguard Capital Opportunity Inv | 2.34M | 4.59% | - |
| Fidelity Growth Compy Commingled Pl S | 1.43M | 2.81% | -184.00K |
| BB Biotech AG Ord | 1.21M | 2.41% | - |
| Fidelity Growth Compy Commingled Pl O | 1.15M | 2.30% | 101.00 |
| PRIMECAP Odyssey Aggressive Growth | 1.11M | 2.19% | -30.00K |
| Fidelity Growth Company Fund | 1.02M | 2.00% | -105.97K |
| T. Rowe Price U.S. SC Core Eq Tr-Z | 902.33K | 1.83% | 44.96K |
| T. Rowe Price U.S. SC Value Eq Tr-Z | 737.44K | 1.49% | 20.48K |
| T. Rowe Price Instl Small-Cap Stock | 685.13K | 1.35% | -482.39K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 18, 2026 | Jallal Bahija | CHIEF EXECUTIVE OFFICER | Sell | $371.18K |
| Feb 18, 2026 | GOLL JOHN | SVP, FINANCE & CAO | Sell | $22.58K |
| Feb 18, 2026 | St Leger Tina Amber | CHIEF HR OFFICER | Sell | $32.35K |
| Feb 18, 2026 | Berman David M | HEAD OF R&D | Sell | $192.97K |
| Dec 04, 2025 | Berman David M | HEAD OF R&D | Sell | $1.26M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | 4 |
| 2025 Q4 | - | 6 |
| 2025 Q3 | - | 7 |
| 2025 Q2 | - | - |
IMCR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools